Delisting risk
Vaxart
Clinical-stage biotech developing oral tablet vaccines for infectious disease.
$0.5083
After-hours close+0.00 (+0.26%)
At close$0.5070(+0.74%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.01%27.1K sharesInsiders 3.20%7.75M sharesOther 96.79%234.26M shares
Shares outstanding 242.04M · Float 238.37M · 98.5% free float
Institutions13F, as of Mar 31, 2026
4 holders · 27.1K shares · 2 new positions · 2 increased · 0 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| LVM Capital Management Ltd/MI | 25.0K | 0.01% | 0 | Apr 2, 2026 |
| Golden State Equity Partners | 2.0K | 0.00% | +2.0Knew | Apr 28, 2026 |
| First Command Advisory Services, Inc. | 40 | 0.00% | +40new | May 7, 2026 |
| Archer Investment Corp | 15 | 0.00% | 0 | May 4, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Steven Lo | director, officer: President, Chief Exec Officer | 2.59M | 1.07% | Mar 26, 2026 |
| James F. Cummings | officer: Chief Medical Officer | 924.2K | 0.38% | Mar 31, 2026 |
| Sean Tucker | officer: SVP, Chief Scientific Officer | 882.8K | 0.36% | Mar 31, 2026 |
| Edward B. Berg | officer: SVP, General Counsel | 755.4K | 0.31% | Mar 26, 2026 |
| Michael J. Finney | director | 702.8K | 0.29% | Jun 16, 2025 |
| Phillip E. Lee | officer: Chief Financial Officer | 631.6K | 0.26% | Mar 26, 2025 |
| Jeroen Nicolaas Grasman | officer: Chief Financial Officer | 545.6K | 0.23% | May 21, 2026 |
| Kevin Finney | director | 244.2K | 0.10% | Jul 20, 2026 |
| W. Mark Watson | director | 173.5K | 0.07% | Jul 17, 2026 |
| Elaine J. Heron | director | 136.0K | 0.06% | Jul 17, 2026 |
2 ten-percent owners hold 30.79M shares by Form 4, outside the officers-and-directors figure above · 43 people have not refiled in the last 18 months (62.28M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 22, 2026 | W. Mark Watsondirector | Purchase | 10,000 | $0.6530 | 134,125 |
| Nov 17, 2025 | W. Mark Watsondirector | Purchase · 2 lots | 20,000 | $0.4093 | 124,125 |
| Nov 17, 2025 | Elaine J. Herondirector | Purchase · 2 lots | 40,000 | $0.3980 | 96,566 |
CongressHouse and Senate disclosures
Not reported.